Crossref journal-article
Rockefeller University Press
The Journal of experimental medicine (291)
Abstract

CD2 is an intercellular adhesion molecule that has been implicated in T cell activation and differentiation both in humans and mice. Although the ligand for human CD2 has been defined as LFA-3, that for murine CD2 has not been identified yet. To identify the ligand for mouse CD2, we generated a chimeric molecule consisting of the extracellular domain of mouse CD2 and human immunoglobulin (Ig)G1 Fc (mCD2Rg). A hamster monoclonal antibody (mAb), HM48-1, was established by screening mAbs that could block the binding of mCD2Rg to T cell lines at the ligand site. The putative mouse CD2 ligand recognized by this mAb was a glycosyl phosphatidylinositol-anchored glycoprotein with an apparent molecular mass of 45 kD, which were shared characteristics with human LFA-3. However, its expression was predominantly restricted to hematopoietic cells, unlike human LFA-3. Protein microsequencing analysis for the NH2-terminal 18 amino acid residues of the affinity-purified HM48-1 antigen revealed that it is almost identical with mouse CD48. This identity was further confirmed by the reactivity of HM48-1 with a soluble recombinant CD48 (sCD48) protein and the molecule recognized by a rat mAb raised against sCD48. A rat anti-CD48 mAb blocked the mCD2Rg binding as well as HM48-1. Moreover, sCD48 also inhibited the mCD2Rg binding to the cellular ligand. Finally, like anti-CD2 mAb, HM48-1 inhibited the phytohemagglutinin response and, when crosslinked, augmented the anti-CD3 response of splenic T cells. These results indicate that CD48 is a ligand for mouse CD2 and is involved in regulating T cell activation.

Bibliography

Kato, K., Koyanagi, M., Okada, H., Takanashi, T., Wong, Y. W., Williams, A. F., Okumura, K., & Yagita, H. (1992). CD48 is a counter-receptor for mouse CD2 and is involved in T cell activation. The Journal of Experimental Medicine, 176(5), 1241–1249.

Authors 8
  1. K Kato (first)
  2. M Koyanagi (additional)
  3. H Okada (additional)
  4. T Takanashi (additional)
  5. Y W Wong (additional)
  6. A F Williams (additional)
  7. K Okumura (additional)
  8. H Yagita (additional)
References 0 Referenced 167

None

Dates
Type When
Created 21 years, 2 months ago (June 24, 2004, 3:56 a.m.)
Deposited 2 years, 1 month ago (July 25, 2023, 12:47 a.m.)
Indexed 2 months ago (June 27, 2025, 9:45 a.m.)
Issued 32 years, 10 months ago (Nov. 1, 1992)
Published 32 years, 10 months ago (Nov. 1, 1992)
Published Online 32 years, 10 months ago (Nov. 1, 1992)
Published Print 32 years, 10 months ago (Nov. 1, 1992)
Funders 0

None

@article{Kato_1992, title={CD48 is a counter-receptor for mouse CD2 and is involved in T cell activation.}, volume={176}, ISSN={1540-9538}, url={http://dx.doi.org/10.1084/jem.176.5.1241}, DOI={10.1084/jem.176.5.1241}, number={5}, journal={The Journal of experimental medicine}, publisher={Rockefeller University Press}, author={Kato, K and Koyanagi, M and Okada, H and Takanashi, T and Wong, Y W and Williams, A F and Okumura, K and Yagita, H}, year={1992}, month=nov, pages={1241–1249} }